NCT03518359.
Study name |
Public title: Enhanced Stress Resilience Training for Residents (ESRT‐R) Scientific title: Enhanced resilience training to improve mental health, stress and performance in resident physicians |
Methods |
Study design: 2‐arm RCT Study grouping: parallel assignment Unit of randomisation: individuals Power (power sample size calculation, level of power achieved): not specified Imputation of missing data: not specified |
Participants |
Country: USA Setting: Emergency Medicine, Internal Medicine, Paediatrics, Family Practice, Obstetrics and Gynaecology (OBGYN) and Surgery Departments of University of California San Francisco Age: see inclusion criteria; age not specified Sample size (randomised): 45 (actual enrolment) Sex: not specified Comorbidity (mean (SD) of respective measures in indicated, if available) at baseline: not specified, but participants with lifetime history of organic mental illness excluded Population description: resident physicians/medical interns Inclusion criteria: 1) any consented medical intern from Emergency Medicine, Internal Medicine, Paediatrics, Family Practice, OBGYN and Surgery Departments in‐coming to University of California San Francisco in the study year; 2) aged 18 ‐ 64 years Exclusion criteria: 1) current personal mindfulness practice, once a week or more frequent; 2) use of medications with Central Nervous System effects; 3) lifetime history of an organic mental illness; 4) acute or chronic immune or inflammatory disorders; 5) pregnancy Attrition (withdrawals and exclusions): not specified Reasons for missing data: not specified |
Interventions |
Intervention: Enhanced Stress Resilience Training (ESRT) (n not specified)
Control: active control (n not specified)
|
Outcomes |
Outcomes collected and reported:
Outcomes reported: not specified Time points measured and reported: 1) pre‐intervention; 2) post‐intervention (9 ‐ 10 weeks after baseline); 3) 6‐month follow‐up; time points reported not specified Adverse events: not specified |
Starting date | Study start/end date: June 2018; estimated primary completion date: June 2021; estimated study completion date: June 2022; active, not recruiting according to trial registration |
Contact information |
Principal investigator: Carter K Lebares, MD; Ekaterina V Guvva, BS Address: University of Californisa, San Francisco, California, United States, 94143 Email: carter.lebares@ucsf.edu; ekaterina.guvva@ucsf.edu Telephone: 415‐502‐5588 |
Notes |
Contact with authors: We contacted the authors for the trial status. According to the authors, the recruitment for study is closed and the results will be published in the next 6 months (Guvva 2019 [pers comm]). Funding source: University of California, San Francisco Declaration of interest: not specified Ethical approval needed/obtained for study: not specified Comments by study authors: not specified Miscellaneous outcomes by the review authors: trial registration number: NCT03518359 (assigned 8 May 2018) |